Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 05, 2021

SELL
$16.62 - $18.94 $6,614 - $7,538
-398 Closed
0 $0
Q1 2021

May 07, 2021

BUY
$15.15 - $19.78 $1,121 - $1,463
74 Added 22.84%
398 $7,000
Q3 2020

Nov 12, 2020

SELL
$15.4 - $20.16 $277 - $362
-18 Reduced 5.26%
324 $6,000
Q2 2020

Aug 13, 2020

SELL
$18.24 - $21.45 $20,209 - $23,766
-1,108 Reduced 76.41%
342 $6,000
Q1 2020

May 12, 2020

BUY
$16.28 - $25.63 $23,606 - $37,163
1,450 New
1,450 $29,000

Others Institutions Holding GRFS

About Grifols SA


  • Ticker GRFS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 678,910,976
  • Market Cap $5.57B
  • Description
  • Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...
More about GRFS
Track This Portfolio

Track Sowell Financial Services LLC Portfolio

Follow Sowell Financial Services LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sowell Financial Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sowell Financial Services LLC with notifications on news.